Related references
Note: Only part of the references are listed.Cancer-Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Hannah J. Vaughan et al.
ADVANCED MATERIALS (2020)
Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management
Da Huo et al.
ADVANCED MATERIALS (2020)
Tumor heterogeneity and clonal cooperation influence the immune selection of IFN-γ-signaling mutant cancer cells
Jason B. Williams et al.
NATURE COMMUNICATIONS (2020)
Multistage Sensitive NanoCRISPR Enable Efficient Intracellular Disruption of Immune Checkpoints for Robust Innate and Adaptive Immune Coactivation
Ning Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Chlorin e6 and CRISPR-Cas9 dual-loading system with deep penetration for a synergistic tumoral photodynamic-immunotherapy
Chengli Yang et al.
BIOMATERIALS (2020)
Virus-like nanoparticle as a co-delivery system to enhance efficacy of CRISPR/Cas9-based cancer immunotherapy
Qi Liu et al.
BIOMATERIALS (2020)
Reduced expression of phosphatase PTPN2 promotes pathogenic conversion of Tregs in autoimmunity
Mattias N. D. Svensson et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Stabilized Molybdenum Trioxide Nanowires as Novel Ultrahigh-Capacity Cathode for Rechargeable Zinc Ion Battery
Xinjun He et al.
ADVANCED SCIENCE (2019)
Cancer nanomedicine for combination cancer immunotherapy
Jutaek Nam et al.
NATURE REVIEWS MATERIALS (2019)
Delivery of CRISPR/Cas9 for therapeutic genome editing
Xiaojie Xu et al.
JOURNAL OF GENE MEDICINE (2019)
Dual-Locking Nanoparticles Disrupt the PD-1/PD-L1 Pathway for Efficient Cancer Immunotherapy
Zhanzhan Zhang et al.
ADVANCED MATERIALS (2019)
NanoRNP Overcomes Tumor Heterogeneity in Cancer Treatment
Qi Liu et al.
NANO LETTERS (2019)
CRISPR-Cas: a tool for cancer research and therapeutics
Hao Yin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Emerging Nano-/Microapproaches for Cancer Immunotherapy
Yu Mi et al.
ADVANCED SCIENCE (2019)
Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo
Qi Liu et al.
ADVANCED SCIENCE (2019)
Hyaluronic Acid-Based Activatable Nanomaterials for Stimuli-Responsive Imaging and Therapeutics: Beyond CD44-Mediated Drug Delivery
Ki Young Choi et al.
ADVANCED MATERIALS (2019)
The Effect of Molecular Structure on Cytotoxicity and Antitumor Activity of PEGylated Nanomedicines
Wenhai Lin et al.
BIOMACROMOLECULES (2018)
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression (vol 128, pg 805, 2018)
Heng Lin et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Design of Polymeric Gene Carriers for Effective Intracellular Delivery
Wing-Fu Lai et al.
TRENDS IN BIOTECHNOLOGY (2018)
Combined local immunostimulatory radioisotope therapy and systemic immune checkpoint blockade imparts potent antitumour responses
Yu Chao et al.
NATURE BIOMEDICAL ENGINEERING (2018)
PTPN2 as a promoter of colon carcinoma via reduction of inflammasome activation
Marianne R. Spalinger et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
PTPN2: a tumor suppressor you want deleted?
Florian Wiede et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
Vikram R. Juneja et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Robert T. Manguso et al.
NATURE (2017)
Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies
David J. Byun et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Levi J. Rupp et al.
SCIENTIFIC REPORTS (2017)
Tumor penetrating peptides for improved drug delivery
Erkki Ruoslahti
ADVANCED DRUG DELIVERY REVIEWS (2017)
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade Enhanced Cancer Photodynamic Immunotherapy
Dangge Wang et al.
NANO LETTERS (2016)
Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR
Michael Boettcher et al.
MOLECULAR CELL (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Enhancing endosomal escape for nanoparticle mediated siRNA delivery
Da Ma
NANOSCALE (2014)
A Reactive Oxygen Species (ROS)-Responsive Polymer for Safe, Efficient, and Targeted Gene Delivery in Cancer Cells
Min Suk Shim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Effect of molecular weight of amine end-modified poly(β-amino ester)s on gene delivery efficiency and toxicity
Ahmed A. Eltoukhy et al.
BIOMATERIALS (2012)
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection
Arlene H. Sharpe et al.
NATURE IMMUNOLOGY (2007)
Share Paper
